All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | TCR Clone | Host Species | Epitope | Allele | Vector Type | Inquiry & Datasheet |
TCR-YC0456 | Human anti-glia-α1a T cell receptor (1383P.A.3), pCDTCR1 | Wheat | 1383P.A.3 | Human | PFPQPELPY | HLA-DQ2.5 | Lentiviral vector | |
TCR-YC0457 | Human anti-glia-α1a T cell receptor (1383P.A.4), pCDTCR1 | Wheat | 1383P.A.4 | Human | PFPQPELPY | HLA-DQ2.5 | Lentiviral vector | |
TCR-YC0458 | Human anti-glia-α1a T cell receptor (442D.A.45), pCDTCR1 | Wheat | 442D.A.45 | Human | PFPQPELPY | HLA-DQ2.5 | Lentiviral vector | |
TCR-YC0459 | Human anti-glia-α1a T cell receptor (S2), pCDTCR1 | Wheat | S2 | Human | glia-α1a | HLA-DQ2.5 | Lentiviral vector | |
TCR-YC0460 | Human anti-glia-α1a T cell receptor (S2.8), pCDTCR1 | Wheat | S2.8 | Human | glia-α1a | HLA-DQ2.5 | Lentiviral vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION